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ABSTRACT 
 
There is strong biological evidence relating alterations in the serotonergic system with 
mental disorders. These alterations may be originated at the DNA level by sequence 
mutations that alter the functioning of serotonin receptors and transporter. To test this 
hypothesis we investigated three genetic variants of the 5-HT2A receptor (-1438G/A, 
102T/C and His452Tyr) and two variants of the serotonin transporter (a VNTR in the 
second intron and a 44 bp insertion/delition in the promoter region of the gene) in a 
clinical sample recruited in a human isolate and in surrounding areas in Northern Spain 
(N = 257) and in ethnically matched controls (N = 334). No clear association was found 
between 5-HT2A variants and psychosis. However, marginal associations were 
observed between the 5-HTT LPR and VNTR variants and psychosis (P≤0.05) 
indicating a minor contribution to psychosis of genetic alterations in this gene.  
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INTRODUCTION 
 
The serotonergic system has been suggested to regulate sleep, appetite, pain, and sexual 
behaviour and to contribute to anxiety, mood disorders, suicidal behaviour and 
additional symptomatology related to psychotic disorders. This hypothetical 
involvement of the serotonergic system in the aetiology of mental disorders has been 
supported by alterations in the expression of serotonin (5-HT) receptors and transporter 
observed in the brain of patients with schizophrenia [Burnet et al., 1996; Hernandez and 
Sokolov, 1997; Dean et al., 1999; Pralong et al., 2000]. Epidemiological studies have 
proved the genetic contribution to the development of mental disorders [McGuffin et 
al., 2002] and mutations in serotonin proteins may be responsible for system alterations. 
However, association and linkage genetic studies have failed to produce consistent 
results supporting the involvement of serotonergic mutations in mental illnesses such as 
schizophrenia and bipolar disorder. Polymorphisms in the gene coding for 5-HT2A 
receptors have been related to schizophrenia, bipolar disorder and psychotic 
symptomatology [Inayama et al., 1996; Williams et al., 1996; Du et al., 1999; Joober et 
al., 1999; Nacmias et al., 2001; Araga and Narasu, 2002; Bonnier et al., 2002; Golimbet 
et al., 2002]. Genetic variants of the serotonin transporter (5-HTT) have also been 
associated with psychotic disorders [Collier et al., 1996; Malhotra et al., 1998; 
Hranilovic et al., 2000; Kaiser et al., 2001; Tsai et al., 2002]. However, there is also a 
wealth of publications that fail to support these findings [Gutierrez et al., 1995; Arranz 
et al., 1996; Rao et al., 1998; Shinkai et al., 1998; He et al., 1999; Oliveira et al., 2000; 
Haider and Zahid, 2002; Serretti et al., 2002]. Discordant findings in studies of complex 
genetic diseases have been attributed to disease heterogeneity although other factors 
such as sample size, ethnic origin and symptomatology may also influence results. We 
have tried to clarify these results by investigating serotonergic polymorphisms in a 
relatively large cohort of psychotic patients (N = 257) and controls (N = 334). A 
subgroup of this cohort (N = 162 patients and 180 controls) was recruited from a 
population isolate from North Navarre (Spain) where the Basque population originated. 
It has been suggested that the lower level of heterogeneity present in isolate populations 
may help the identification of genetic factors contributing to complex diseases. Three 
polymorphisms in the 5-HT2A receptor gene (102T/C, -1438G/A and His452Tyr) and 
two polymorphisms previously described in the 5-HTT gene (designated as LPR and 
VNTR) were investigated in the samples and compared with ethnically matched 
controls to investigate their contribution to mental disorders. The results showed 
marginal associations (P<0.05) between the 5-HTT LPR and VNTR polymorphisms and 
schizophrenia, although no significant differences were observed in the distribution of 
5-HT2A variants between patients and controls. Our results do not support a major role 
of the serotonergic system on the aetiology of schizophrenia, although a minor 
contribution of the serotonin transporter is likely. 
 
 
 
MATERIALS AND METHODS 
 
Clinical Sample 
 
Patient sample. Two hundred and fifty seven subjects (153 males and 104 females) 
suffering from psychotic disorders (DSM-IV diagnosis) were recruited for the study. 
One hundred and eighty two of the patients had a diagnosis of schizophrenia and 18 of 
schizo-affective disorder, 28 subjects suffered from bipolar disorder, 15 subjects 
suffered from major depression, 7 subjects presented delusional disorder and 7 brief 
psychotic disorders. Patients were recruited in several medical centres in Pamplona 
(Navarre, Spain) and were of Spanish origin (N= 95: 77 schizophrenia, 9 schizo-
affective disorder, 3 bipolar disorder, 1 major depression, 5 brief psychotic disorder) or 
were recruited from an isolate area in the Northern part of Navarre and were of Basque 
origin (N= 162: 105 schizophrenia, 9 schizo-affective disorder, 25 bipolar disorder, 14 
major depression, 7 delusional disorder, 2 brief psychotic disorder). The Basques 
constitute one of the oldest human isolates and present several unique characteristics 
that differentiate them from other Spanish and European populations [Bertranpetit and 
Cavalli-Sforza, 1991]. In addition, the small population size and the geographical 
isolation of the area in North Navarre where this sample was collected guarantee low 
genetic heterogeneity and high level of linkage disequilibrium, two characteristics that 
should help to identify genes implicated in complex disorders. The ethnic origin of all 
subjects was confirmed at grandparent level. The average age of the patient subjects was 
40.66 (SD =14.43) and the mean for age of onset was 23.78 (SD = 8.08). 
 
Control sample. Ethnically matched samples consisting of 154 controls of Spanish 
origin and 180 of Basque origin (collected in the same isolate area than the patients) 
were recruited in blood bank centres. The average age of the control sample was 26.89 
(S.D = 5.45) and the gender distribution was 177 males and 157 females. This relatively 
large cohort has a statistical power of more than 85% to detect genetic effects with an 
odds ratio superior to 2.00 for polymorphisms with a frequency of 10%. Informed 
consent was obtained from all participants in the study. Ethical approval was granted by 
the respective committes of all collaborating institutions. 
 
 
Genotype Characterisation 
 
Three 5-HT2A polymorphisms (102T/C, —1438G/A, His452Tyr) and two 5-HTT 
polymorphisms (a VNTR in the second intron, and a polymorphic insertion/deletion of a 
44 bp fragment located in the promoter region of the gene, designated as 5-HTT LPR) 
were investigated in the samples. Duplicate independent assays were performed for each 
individual and polymorphism. The PCR methods used were similar to those described 
elsewhere [Arranz et al., 1995; Arranz et al., 1996; Collier et al., 1996]. Fluorescent 
labels (FAM and HEX) were added to the 5' end of primers to facilitate the genotyping 
process using an ABI 3100 automated genotyper (samples prepared for automatic 
genotyping following manufacturer’s instructions). 
 
 
Statistical Analyses 
 
As the clinical samples consisted of two population groups of different ethnic origin, 
stratified analyses were performed for all comparisons. Chi-square comparisons were 
performed using SPSS (version 10.0) and EPIInfo2000 statistical packages. Haplotype 
analyses were performed using the EHPlus programme [Zhao et al., 2000]. 
 
 
 
 
RESULTS 
 
5-HT2A 102T/C 
 
A total of 244 patients and 309 controls were analysed for this polymorphism (see Table 
I). A similar trend to that observed in previous studies was observed in the genotype 
distribution between patients and controls: individuals homozygous for the 102-C 
variant were relatively more frequent in psychotic patients than in controls (29 and 27% 
for Basque patients and controls, 25 and 24% for Spanish patients and controls 
respectively). This trend was slightly increased when only schizophrenic and schizo-
affective patients were considered: an average of 30% patients presented the 102-C/ C 
genotype in comparison to 25% on average in controls presented. However, these 
differences did not reach statistical significance (χ2 = 1.73, P = 0.42 and χ2 = 0.24, P = 
0.89 for Basque and Spanish samples respectively; χ2 =1.73, P = 0.42 for stratified 
analyses). No differences in allelic distribution were observed between patients and 
controls (frequency of 102-T = 0.45–0.48, frequency of 102-C = 0.52–0.56 in both 
diagnostic and ethnic groups). 
 
 
5-HT2A —1438G/A 
 
Table II summarises the results for this polymorphism. A total of 239 patients and 305 
control subjects were investigated. Nearly complete linkage disequilibrium was 
observed between the -1438G/A and 102T/C polymorphisms in both Spanish and 
Basque subjects. As expected, the results were similar to those of 102T/C, the only 
differences being the result of failed PCR assays in several samples. Individuals with 
the -1438G/G genotype were slightly more frequent in patients (28–31%) than controls 
(27% on average) without reaching statistical significance (stratified analyses of 
genotypes vs. disease: χ2 =1.36, P= 0.51; χ2 = 3.23, P = 0.20 when only schizophrenic 
and schizo-affective patients were considered). Allele frequencies were again similar in 
patients and controls (frequency of -1438G: 0.55–56, frequency of -1438A: 0.44–46, on 
average). 
 
 
5-HT2A His452Tyr 
 
This polymorphism was found in 18% of patients and 15% of controls (Table III). 
Allele and genotype distributions were similar in Basques and Spanish, and among 
patients and controls. Slightly higher frequencies of individuals heterozygous were 
found in patients (16% in Basques and 21% in Spanish) than in controls (14 and 16% 
for Basque and Spanish controls respectively). The frequency of the rare allele, Tyr452, 
ranged from 0.09 to 0.11 in patients to 0.07–0.08 in controls. These differences did not 
reach statistical significance (P > 0.30 for all comparisons). 
 
 
5-HTT LPR 
 
Individuals homozygous for the 480 bp allele were more frequently detected among 
controls (36% of Basque controls and 29% of Spanish controls presented the 480/480 
bp genotype, vs. 31 and 20% of Basque and Spanish patients respectively, Table IV). 
Stratified analysis of these results showed a marginal association between genotype 
distribution and psychosis (χ2 = 6.04, P = 0.05, stratified analyses). A similar 
observation was obtained when comparing the subgroup of schizophrenic and schizo-
affective patients (24% of 480 bp homozygotes) versus controls (33%) (χ2 =6.20, 
P=0.045). Comparisons of allelic distribution produced no significant values (P > 0.20 
for all comparisons). The frequency of allele 480 bp ranged from 0.50 to 0.57 in 
patients and controls. 
 
 
5-HTT VNTR 
 
Three allelic variants of this polymorphism (9, 10 and 12 repeats) were detected in the 
samples (Table V). Schizophrenic patients presented a higher proportion of 12 repeat 
homozygotes (45% of Basque patients and 47% of Spanish patients) than controls (41 
and 36% of Basque and Spanish controls respectively; χ2 = 5.15, P = 0.16). Chi-square 
comparisons of allelic distribution revealed a significant difference of the 12 repeat 
allele frequency in patients versus controls (0.69 and 0.65 in Basque patients and 
controls, and 0.68 and 0.58 in Spanish patients and controls respectively; χ2 = 3.89, P = 
0.05). Similar genotype and allele distributions were observed in the 
schizophrenia/schizo-affective subgroup, although comparisons versus frequencies in 
controls did not reveal statistically significant differences probably due to the reduction 
in sample since P > 0.05 for all comparisons. 
 
 
Haplotype Analyses 
 
Haplotype analyses showed strong linkage disequilibrium between the three 5-HT2A 
polymorphisms investigated, independent of disease (χ2 = 888, df = 7, P < 0.0001). 
However, no haplotype combination was found to be associated with disease phenotype 
(χ2 = 8.82, df = 7, P = 0.27). Similar results were obtained for 5-HTT haplotype 
comparisons between patients and controls: the 5-HTT VNTR and LTR polymorphisms 
were found in strong linkage disequilibrium (χ2 = 62.87, df = 3, P < 0.0001) but no 
differences in haplotype combinations were observed between patients and controls    
(χ2 = 6.04, df = 3, P = 0.11). 
 
 
DISCUSSION 
 
The serotonergic hypothesis of schizophrenia suggests that alterations in this 
neurotransmitter system may be related to the aetiology of the disease [Meltzer, 1999]. 
Genetic polymorphisms may contribute to these alterations and this possibility has been 
the subject of extensive study. Previous association studies on 5 HT2A and 5-HTT 
polymorphisms showed contradicting results that may have been affected by sample 
size and genetic heterogeneity. We tried to clarify these results by genotyping five 
serotonergic polymorphisms in a relatively large sample of psychotic patients and 
controls from Northern Spain, including individuals from a human isolate of Basque 
origin in Navarre. 
 
Three polymorphisms in the gene coding for the 5-HT2A receptor (102T/C, -1438G/A 
and His452Tyr) and two genetic variants in the serotonin transporter (5-HTT) gene were 
genotyped in the samples. Although the Basques constitute one of the oldest human 
isolates with unique characteristics [Bertranpetit and Cavalli-Sforza, 1991] no 
significant differences were observed in the genotype or allelic distribution between 
Spanish and Basque individuals for any of the polymorphisms investigated. 
Furthermore, when differences in genotype or allele frequency distribution were 
observed between psychotic patients and controls, a similar trend was observed in the 
Spanish and Basque samples, indicating a similar contribution to psychotic disorders (or 
lack of involvement) in both populations. 
 
Our results failed to show any significant difference in the genotype or allele 
distribution of 5-HT2A variants in any of the subgroups and comparisons considered. In 
addition, there was no clear trend of differential distribution between patients and 
controls. These results could not confirm previous findings of association with 
schizophrenia [Inayama et al., 1996; Williams et al., 1996; Joober et al., 1999; Araga 
and Narasu, 2002]. However, it is likely that serotonergic associations are stronger 
when specific phenotypes such as suicidal behaviour and clinical dimensions are 
considered [Bonnier et al., 2002; Golimbet et al., 2002] and therefore could not be 
detected in our sample. Alleles 102T and -1438A, and alleles 102C and -1438G were in 
nearly complete linkage disequilibrium in both populations. Similar linkage status has 
been observed in other European populations [Arranz et al., 1998]. 
 
Marginal associations of 5-HTT polymorphic variants with schizophrenia were detected 
in our sample. Association was observed between the 5-HTT LPR polymorphism and 
schizophrenia, with a slightly higher frequency of the allele 528 bp observed in patients. 
These frequencies differ slightly from those observed in other Spanish populations 
[Gutierrez et al., 1998] and may be caused by heterogeneity or chance finding. A 
marginal association was also observed with the 5-HTT VNTR polymorphism: an 
excess of the 12 repeat allele was observed in patients in comparison with controls (P = 
0.05). This finding had also been found in Chinese and European schizophrenic patients 
[Hranilovic et al., 2000; Tsai et al., 2002], patients suffering schizoparanoid disorders 
[Kaiser et al., 2001] and bipolar patients [Collier et al., 1996]. Although our results 
would not be statistically significant if Bonferoni corrections were applied, the 
coincidence with previous findings strengthens the hypothesis of a minor contribution 
of 5-HTT polymorphisms in the aetiology of psychotic disorders. 
 
In summary, our results do not support a major involvement of 5-HT2A genetic variants 
in the aetiology of schizophrenia. However, the marginal associations observed with 5-
HTT variants indicate a minor contribution to the disease. It is likely that stronger 
associations can be found when specific clinical dimensions are investigated, especially 
if a low heterogeneity sample is used. 
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